site stats

Epha2 in cancer

Web[目的]探讨EphA2在结直肠癌细胞中的生物学功能及其信号调控机制.[方法]qRT-PCR法检测EphA2在结直肠癌细胞系中的表达情况,筛选得到表达量较高细胞株系,利用siRNA沉默该细胞系中EphA2的表达,利用MTT、Transwell、Western blot、qRT-PCR法检测细胞生物学功能变 … WebMembrane-bound erythropoietin-producing hepatocellular receptor tyrosine kinase class A2 (EphA2) is overexpressed in breast, prostate, urinary bladder, skin, lung, ovary and brain cancers. Areas covered in this review: EphA2 overexpression in cancers, its signaling mechanisms and strategies to target its deregulation.

Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer

WebConsidering that EphA2 signaling in cancers is complex, even diametrically opposite, 17–20 the results suggested that EphA2 signaling in SCLC might also be complex. Enlarge this image. FIGURE 1. Ligand-independent phosphorylation of EphA2 is related to chemoresistance of SCLC. WebEphA2 tyrosine kinase is upregulated in many cancers and correlated with poor survival of patients, including those with endometrial cancer. EphA2-targeted drugs have shown … ross burke and knobel reno https://starlinedubai.com

Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary …

WebEPHA2. General description of the gene and the encoded protein (s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project. … WebOct 20, 2024 · EphA2 expression was detected in 80-100% of bladder cancer samples and correlated with shorter patient survival. EphA2 was found to be expressed in tumor cells … Webtern of EphA2 in colorectal cancer, where overexpression seemed to be most prevalent in stage 1 and 2 [46]. Similar to other Eph receptors, the EphA2 receptor can be activated through ligand-independent signaling. In glio-blastoma cell lines, the overexpression of EphA2 stimulates the tyrosine kinase activity, which activates ERK, and results stormwatch overland park

Bicycle Therapeutics to Present at the 2024 AACR Annual Meeting

Category:IJMS Free Full-Text MicroRNA-944 Affects Cell Growth by …

Tags:Epha2 in cancer

Epha2 in cancer

Oncogenic functions and therapeutic targeting of EphA2 …

WebEphrin type-A receptor 2 (EphA2) is overexpressed in multiple types of cancers such as breast, melanoma, ovarian adenocarcinoma. 11–13 Due to its strong association with tumor progression, metastasis, and prognosis, EphA2 is considered a possible therapeutic target, as well as a diagnostic and prognostic marker. WebSep 26, 2016 · Lung cancer is the leading cause of cancer death worldwide, with increasing incidence and mortality. Among all types of lung cancer, non-small cell lung cancer ... (EPHA7 TR) was revealed as a soluble tumor suppressor for follicular lymphoma by inhibiting EPHA2 signaling , which makes EPHA7 a promising targeted therapeutic …

Epha2 in cancer

Did you know?

WebFeb 22, 2024 · The EphA2 receptor tyrosine kinase is capable of activating multiple diverse signaling pathways with roles in processes such as tissue homeostasis and cancer. EphA2 is known to form activated... WebWild-type EphA2 enhances cancer stemness and chemoresistance of SCLC, while P817H mutation neutralizes intrinsic function. To further explore the effect of EphA2 on …

WebApr 14, 2024 · Abstract Number: 1826. Speaker/Lead Author: Lukas Stanczuk, Bicycle Therapeutics. Title: EphA2-dependent CD137 agonism and anti-tumor efficacy by … WebJul 30, 2024 · In the study by Yoon et al. (2024) mentioned above, the effect of SAM domain linker (amino acids 901–929) mutations in conferring paclitaxel resistance in several cancer cell lines were attributed to the inability of mutated EphB6 to recruit the ubiquitin ligase c-Cbl to EphB6-EphA2 protein clusters. The inability to recruit c-Cbl by EphB6 ...

WebMay 3, 2024 · EphA2 is a key member of the receptor tyrosine kinase (RTK) family that plays important roles in multiple physiological and pathological processes. Accumulating evidence suggests that EphA2 is... WebThe EphA2 receptor is found at high levels in tumors and low levels in normal tissue and high EphA2 expression in biopsies is a predictor of poor outcome in patients. Drug discovery groups have therefore sought to develop EphA2-based therapies using small molecule, peptide, and nanoparticle-based approaches (1-3).

WebNational Center for Biotechnology Information

WebSep 26, 2016 · Lung cancer is the leading cause of cancer death worldwide, with increasing incidence and mortality. Among all types of lung cancer, non-small cell lung cancer ... storm watch price xboxWebAug 18, 2024 · In particular, we focused on EphA2’s potential as a target for cancer treatment to provide insights into the application of EphA2 targeting in anticancer strategies. Overall, EphA2 represents a ... stormwatch protectionWebApr 23, 2024 · EphrinA-mediated EphA2 receptor tyrosine kinase activation is linked to tumor-suppressive signaling, and thus disfavored in cancer cells 12, 37, 38. Considering the inverse contribution of... storm watch price ps4WebSep 4, 2024 · It is an established fact that most of the solid tumors have overexpression of EPHA2 receptor tyrosine kinase. EPHA2 is known to exhibit opposing roles towards … ross burleyWebThe EPH receptor A2 (EPHA2) gene is a member of the protein-tyrosine kinase subfamily of ephrin receptors and encodes a protein that associates with ephrin-A ligands. Missense … ross burney humeWebApr 20, 2024 · Overall, EphA2 is overexpressed in breast cancer, especially TNBC, and its expression is associated with poor prognosis. EphA2 promotes breast cancer cell … stormwatch rocket leagueWebJun 4, 2024 · EPHA2 is overexpressed in multiple tumor types, and its expression correlates with poor prognosis and therapy resistance ( 25 ). Importantly, the mRNA expression level of EPHA2 negatively correlated with CD8A, CD3, PRF1, and GZMB, but not IFNG, in 2 independent data sets of human PDA samples ( Figure 1D and Supplemental Figure 1, B … ross burney